Torres-Mercado LO, García-Padilla MÁ, Serrano-Brambila E, Maldonado-Alcaraz E, López-Sámano VA, Montoya-Martínez G, Moreno-Palacios J

Language: Spanish
References: 13
Page: 156-161
PDF size: 283.53 Kb.

ABSTRACT

Background: Emphysematous pyelonephritis (EPN) is a severe infection of the urinary tract, caused by gas accumulation within the collecting system, the renal parenchyma, and/or the perirenal tissue. The cause of this infection is not known at all; however, it has been suggested that it is produced by the glucose fermentation provoked by enterobacteriaceae or anaerobic organisms. Our objective was to evaluate the predictors of morbidity and mortality in patients diagnosed with EPN.
Methods: It was carried out a historical cohort study of patients diagnosed with EPN in our hospital from March 2005 to December 2014. Patients with adverse outcome were identified. We defined adverse outcome as patients requiring stay in intensive care unit, who presented nephrectomy and/or who died. A multiple regression analysis was conducted to establish the relation of each clinical factor with the adverse outcome.
Results: 73 records were included for analysis, 48 were women (65.8 %) and 25 men. Diabetes, urolithiasis, E. coli infection and septic shock occurred in 68.5, 68.5, 63, and 15.1 %, respectively. We found that leukocytosis ›12 000 µl (OR 43.65, 95 % CI 2.36-805, p ‹0.001), thrombocytopenia ≤120 000 µl (OR 363, 95 % 9.2-14208, p ‹0.0001), and Huang’s radiological class 3 (OR 62, 95 % CI 4-964, p ‹ 0.001) were factors significantly associated with adverse outcome.
Conclusion: Thrombocytopenia, leukocytosis and Huang’s radiological class 3 are associated with adverse outcome in patients with EPN

REFERENCES

1. Huang JJ, Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis and pathogenesis. Arch Intern Med.2000;160:797-805.

2. Kelly HA, MacCallum WG. Pneumaturia. JAMA. 1898;31:375-81.

3. Huang JJ, Chen KW, Ruaan MK. Mixed acid fermentation of glucose as a mechanism of emphysematous urinary tract infection. J Urol. 1991;146:148-51.

4. Kapoor N, Muruganandham K, Gulia AK, Singla M, AgrawalS, Mandhani A. Predictivefactorsofmortalityand need for nephrectomy in patients with emphysematous pyelonephritis. BJU Int. 2010;105(7):986-9. doi: 10.1111/j.1464-410X.2009.08930.x.

5. Rodríguez-Gallardo JM, Serrano-Brambila E, Maldonado- Alcaraz E, Montoya-Martínez G, Moreno-Palacios J. Experiencia en el manejo de la pielonefritis enfisematosa. Bol Col Mex Urol. 2012; Vol. XXVII: 15-20.

6. Shokeir AA, El-Azab M, Mohsen T, El-Diasty T. Emphysematous pyelonephritis: a 15 year experience with 20 cases. Urology. 1997;49(3): 343-6.

7. Wan YL, Lo SK, Bullard MJ, Chang PL, Lee TY. Predictors of outcome in Emphysematous pyelonephritis. The Journal of Urology. 1998;159:369-73.

8. Fatima R, Jha R, Muthukrishnan J, Gude D, Nath V, Shekhar S, et al. Emphysematous pyelonephritis: a single center study. Indian J Nephrol. 2013;23(2):119-24.

9. Lu YC, Chiang BJ, Pong YH, Chen CH, Pu YS, Hsueh PR, et al. Emphysematous pyelonephritis: clinical characteristics and prognostic factors. Int J Urol. 2014;21(3):277-82.

10. Dhabalia JV, Nelivigi GG, Kumar V, Gokhale A, Punia MS, Pujar N. Emphysematous pyelonephritis: tertiary care center experience in management and review of the literature. Urol Int. 2010;85(3):304-8.

11. Lu YC, Chiang BJ, Pong YH, Huang KH, Hsueh PR, Huang YC, et al. Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis. BMC Infec Dis. 2014;14:418.

12. Falagas ME, Alexiou VG, Giannopoulou KP, Seimpos II. Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis. J Urol. 2007;178(3):880-5.

13. Olvera-Posada D, Armengod-Fischer G, Vázquez- Lavista LG, Maldonado-Avila M, Rosas-Nava E, Manzanilla-García H et al. Emphysematous pyelonephritis: multicenter clinical and therapeutic experience in Mexico. Urology. 2014;83(6):1280-4.